Use of alginate oligomers to enhance the translocation of micro/nanoparticles across mucus layers
AssigneeAlgipharma AS
InventorsAristides Tagalakis, Stephen Hart, Are Kristiansen, Arne Dessen, Philip D. Rye
Life of this patent
Estimating the term…
Loading patent…
AssigneeAlgipharma AS
InventorsAristides Tagalakis, Stephen Hart, Are Kristiansen, Arne Dessen, Philip D. Rye
Estimating the term…
A method for translocating a cationic micro/nanoparticle across a mucus layer, the method including (a) contacting the mucus layer with at least one alginate oligomer, the alginate oligomer having at least 70% mannuronate residues, together with the cationic micro/nanoparticle; or (b)(i) contacting the cationic micro/nanoparticle with an alginate oligomer having at least 70% mannuronate residues thereby forming a micro/nanoparticle carrying the alginate oligomer, and (b)(ii) contacting the mucus layer with the micro/nanoparticle prepared in step (b)(i). There is also provided a method for translocating a molecule of interest across a mucus layer including contacting the mucus layer with a micro/nanoparticle which is formed of self-assembling micro/nanoparticle forming components, wherein at least one is a cationic micro/nanoparticle forming agent and at least one is an alginate oligomer which has at least 70% mannuronate residues, and further comprises the molecule of interest, optionally wherein the molecule of interest is covalently bound to one or more of the self-assembling micro/nanoparticle forming components.
A method for translocating a cationic micro/nanoparticle across a mucus layer said method comprising
Dependencies are inferred from the claim text.